News

Recent News

September 21, 2020

Stevanato Group And Bexson Biomedical Announce Collaboration To Develop A Customized Wearable Ketamine Delivery Device

September 19, 2020

Forbes - This Wearable Ketamine Device Could be the Future of Pain Management

August 4, 2020

Bexson Biomedical To Co-Host Virtual Ketamine Conference

June 30, 2020

Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors

May 26, 2020

Bexson Biomedical Announces Two New Appointments to Board of Directors

March 13, 2020

Ketamine: The Psychedelic Painkiller that Could Halt the Opioid Crisis? Double Blind Magazine

October 8, 2019

Bexson Biomedical’s Chief Scientific Officer speaks to ketamine leaders at ASKP conference

May 15, 2019

Bexson Biomedical files second provisional patent family

February 1, 2019

Bexson Biomedical receives Orphan designation

Presentations

August 2020 -- Investor Presentation